Macrophage Proliferation Machinery Drives Immunosuppression and PDAC Progression (巨噬细胞增值机制抑制肿瘤免疫促进胰腺癌发展)
C Zuo - 2022 - openscholarship.wustl.edu
… treatments for pancreatic cancer are still largely inefficient. Patients with unresectable PDAC
tumors are in a great need of new therapeutic … molecules that inhibit effector T cell functions …
tumors are in a great need of new therapeutic … molecules that inhibit effector T cell functions …
[HTML][HTML] LncRNAs 在胰腺癌中的作用及研究现状
黄劲, 张莉 - Advances in Clinical Medicine, 2023 - hanspub.org
… or the relationship between pancreatic cancer and LncRNA … different stages of pancreatic
cancer development and … have certain significance for early screening and targeted therapy for …
cancer development and … have certain significance for early screening and targeted therapy for …
组蛋白去乙酰化酶SIRT1 对胰腺癌代谢的调控作用
苑宝文, 王沛, 黄蔚 - 山东大学学报(医学版), 2022 - yxbwk.njournal.sdu.edu.cn
… small molecule metabolism. … role in pancreatic cancer metabolism, which paves the way for
future study on the regulatory mechanism of SIRT1 and targeted therapy for pancreatic cancer…
future study on the regulatory mechanism of SIRT1 and targeted therapy for pancreatic cancer…
以多重研究法解開組織缺氧-纖維化循環在胰臟癌之病理機制及發展新穎治療策略-組織缺氧-纖維化循環在胰臟癌生成與進展, 免疫抑制及抗藥性之角色: 聚焦於癌細胞與癌症 …
沈延盛 - 2020 - nckur.lib.ncku.edu.tw
… Hypoxia can in turn affect CAFs by driving their activation and thus … or targeted therapy.
However, the mechanisms that contribute to development and progression of pancreatic tumors …
However, the mechanisms that contribute to development and progression of pancreatic tumors …
[PDF][PDF] 胰腺癌精准治疗的现状和展望
王欢, 金钢 - 中国普通外科杂志, 2021 - zpwz.net
… such as targeted therapy, molecular subtyping and personalized tumor model for pancreatic
cancer, … The four major driver mutations (KRAS/TP53/CDKN2A/ SMAD4) play an important …
cancer, … The four major driver mutations (KRAS/TP53/CDKN2A/ SMAD4) play an important …
工程化间充质干细胞抗肿瘤研究进展*
王沁尧, 王溪溪, 李丽, 胡耀晟… - 中国生物工程 …, 2023 - manu60.magtech.com.cn
… treatment of cancer. Despite the controversial roles of MSC in cancer therapy, engineering …
suicide genes, and oncolytic viruses to tumors. Current clinical trial utilizing engineered MSCs …
suicide genes, and oncolytic viruses to tumors. Current clinical trial utilizing engineered MSCs …
胰腺癌肿瘤微环境的机制及靶向治疗.
张艺, 徐敏 - Journal of Clinical Hepatology/Linchuang …, 2022 - search.ebscohost.com
… of pancreatic cancer and its impact on targeted therapy. Key words:… Extracellular influences:
Molecular subclasses and the … , collagen, and other drivers of tumor progression[J]. Clin …
Molecular subclasses and the … , collagen, and other drivers of tumor progression[J]. Clin …
角鲨烯环氧化酶与癌症的研究进展
郭良琦, 刘亚云, 盛德乔 - 肿瘤防治研究, 2023 - zlfzyj.com
… SQLE may be a potential molecular target for cancer therapy. … 一项研究铁死亡调节 因子对
胰腺癌(pancreatic adenocarcinoma… epoxidase drives NAFLDinduced hepatocellular carcinoma …
胰腺癌(pancreatic adenocarcinoma… epoxidase drives NAFLDinduced hepatocellular carcinoma …
Glucagon‐like peptide 1‐potentiated insulin secretion and proliferation of pancreatic β‐cells GLP‐1促进胰岛素分泌和胰岛β细胞增殖的机制
X Ma, Y Guan, X Hua - Journal of diabetes, 2014 - Wiley Online Library
… Knowledge of the molecular and cellular mechanisms underlying normal … pancreatitis, which
may eventually link to development of more serious pancreatic cancer and thyroid cancer.4 …
may eventually link to development of more serious pancreatic cancer and thyroid cancer.4 …